Conduit Pharmaceuticals Inc (CDT) ニュース
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

CDT

Conduit Pharmaceuticals (CDT)

Conduit Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CDT
日付受信時刻ニュースソース見出しコード企業名
2024/12/1221 : 30GlobeNewswire Inc.Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and CyberneticsNASDAQ:CDTConduit Pharmaceuticals Inc
2024/11/2121 : 30GlobeNewswire Inc.Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune DisordersNASDAQ:CDTConduit Pharmaceuticals Inc
2024/11/2006 : 30GlobeNewswire Inc.Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of DirectorsNASDAQ:CDTConduit Pharmaceuticals Inc
2024/11/0205 : 45GlobeNewswire Inc.Conduit Pharmaceuticals Announces Debt Restructuring and Additional NotesNASDAQ:CDTConduit Pharmaceuticals Inc
2024/08/2821 : 00GlobeNewswire Inc.Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
2024/08/1220 : 00GlobeNewswire Inc.Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune DisordersNASDAQ:CDTConduit Pharmaceuticals Inc
2024/08/0819 : 30GlobeNewswire Inc.Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class TreatmentsNASDAQ:CDTConduit Pharmaceuticals Inc
2024/07/1620 : 30GlobeNewswire Inc.Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune DiseasesNASDAQ:CDTConduit Pharmaceuticals Inc
2024/06/1321 : 00GlobeNewswire Inc.Conduit Pharmaceuticals to Join Russell 3000® IndexNASDAQ:CDTConduit Pharmaceuticals Inc
2024/05/3005 : 21GlobeNewswire Inc.A Presidio Property Trust Major Investment To Be Part of Russell 2000®NASDAQ:CDTConduit Pharmaceuticals Inc
2024/03/1920 : 00GlobeNewswire Inc.Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific OfficerNASDAQ:CDTConduit Pharmaceuticals Inc
2024/03/1120 : 00GlobeNewswire Inc.Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences HubNASDAQ:CDTConduit Pharmaceuticals Inc
2024/01/3122 : 30GlobeNewswire Inc.Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
2023/11/0221 : 30GlobeNewswire Inc.Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
2023/10/1121 : 30GlobeNewswire Inc.Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656NASDAQ:CDTConduit Pharmaceuticals Inc
2023/10/0621 : 30GlobeNewswire Inc.Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)NASDAQ:CDTConduit Pharmaceuticals Inc
2023/09/2222 : 01GlobeNewswire Inc.Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business CombinationNASDAQ:CDTConduit Pharmaceuticals Inc
2003/11/1102 : 26PR Newswire (US)Mohawk/CDT Announces the Release of VersaLite(TM) Indoor/Outdoor Plenum Fiber Optic CableNYSE:CDT
 Showing the most relevant articles for your search:NASDAQ:CDT